Overview
Endovascular Advances: A Hands-on Preceptorship Program
Registration is closed for this activity.
This CME activity is designed to provide physicians with hands-on training in all aspects of managing peripheral arterial disease, including: SFA interventions, chronic limb ischemia, chronic total occlusions, and AV Access. Approved attendees will be trained for a two-day program under the direct supervision of the program faculty at the program site. Attendees can expect to gain exposure to vessel prep in the era of drug elution, atherectomy, CTO crossing strategies, and stenting.
This activity is intended for vascular surgeons, interventional cardiologists, and interventional radiologists looking to expand their hands-on experience in the treatment of peripheral arterial disease and AV access.
Upon completion of this activity, participants will be able to:
• Analyze risk assessment and diagnostic methods in peripheral arterial disease
• Compare and contrast medical, surgical, and endovascular treatment options for peripheral arterial disease
• Formulate strategies to manage potential complications
Heart Hospital of New Mexico at Lovelace Medical Center
504 Elm St. NE
Albuquerque, NM 87102 USA
Click here to view location map
504 Elm St. NE
Albuquerque, NM 87102 USA
Click here to view location map
THURSDAY, APRIL 20
8:00-8:15 Please meet Dr. Henao at the Heart Hospital of New Mexico at Lovelace Medical Center.
(Dr. Henao or a representative will be waiting to meet you in the cafeteria lobby)
8:30-12:00 Discussion and Hands-On cases
12:00-1:00 Lunch in the New Mexico Heart Institute small conference room
1:00-5:00 Discussion and Hands-On Cases
5:00 Course adjourns for the day
FRIDAY, APRIL 21
8:00-8:15 Please meet Dr. Henao at the Heart Hospital of New Mexico at Lovelace Medical Center.
(Dr. Henao or a representative will be waiting to meet you in the cafeteria lobby)
8:30-12:00 Discussion and Hands-On cases
12:00-1:00 Lunch in the New Mexico Heart Institute small conference room
1:00-4:00 Discussion and Hands-On Cases
4:00-4:30 Course adjourns for the day, Course feedback
Supported by an educational grant from Boston Scientific Corporation
Steve Henao, MD, FACC
Heart Hospital of New Mexico
Albuquerque, NM
Heart Hospital of New Mexico
Albuquerque, NM
ACHL requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. Conflict resolution must occur prior to the CME/CE activity. The ACHL also requires participating faculty to disclose when unapproved/unlabeled uses of a product are discussed in a CME/CE activity.
This CME activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. The ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
The faculty member has provided the following disclosure information:
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
To receive credit, participants are required to participate in the live training and complete the online evaluation sent via e-mail following the meeting. Once the online evaluation is completed, a certificate will be immediately
available and also e-mailed. There is no fee for the generation of the certificate.
Inquiries may be directed to the Academy for Continued Healthcare Learning at 773-714-0705, x228.
available and also e-mailed. There is no fee for the generation of the certificate.
Inquiries may be directed to the Academy for Continued Healthcare Learning at 773-714-0705, x228.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this live activity for up to a maximum of 16.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Academy for Continued Healthcare Learning designates this live activity for up to a maximum of 16.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
